{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:27:47Z","timestamp":1790706467472,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020441","name":"Shanghai Center for Brain Science and Brain-Inspired Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["825B2111"],"award-info":[{"award-number":["825B2111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361148716"],"award-info":[{"award-number":["82361148716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030059"],"award-info":[{"award-number":["32030059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124406","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:18:49Z","timestamp":1782343129000},"page":"124406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer"],"prefix":"10.1016","volume":"335","author":[{"given":"Hongrui","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2725","authenticated-orcid":false,"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib1","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ccell.2024.08.002","article-title":"Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer","volume":"42","author":"McIntyre","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124406_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib3","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ccell.2024.08.001","article-title":"The KRAS mutational spectrum and its clinical implications in pancreatic cancer","volume":"42","author":"Perelli","year":"2024","journal-title":"Cancer Cell"},{"issue":"6487","key":"10.1016\/j.biomaterials.2026.124406_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10555-021-10004-4","article-title":"Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets","volume":"40","author":"Andersen","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124406_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124406_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.trecan.2017.08.006","article-title":"KRAS alleles: the devil is in the detail","volume":"3","author":"Haigis","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biomaterials.2026.124406_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","article-title":"The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities","volume":"22","author":"Kung","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7443","key":"10.1016\/j.biomaterials.2026.124406_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-024-00786-4","article-title":"Metabolic interplays between the tumour and the host shape the tumour macroenvironment","volume":"25","author":"Altea-Manzano","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124406_bib12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/0008-5472.CAN-18-0419","article-title":"Nutrient stress-dysregulated antisense lncRNA GLS-AS impairs GLS-mediated metabolism and represses pancreatic cancer progression","volume":"79","author":"Deng","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124406_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","article-title":"A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells","volume":"31","author":"Yoo","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2026.124406_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jare.2025.10.030","article-title":"KRAS\/ACTN4\/p65-NR2A axis mediates glutamine-glutamate metabolic coupling between schwann cells and pancreatic cancer promoting perineural invasion","volume":"85","author":"Tian","year":"2025","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124406_bib15","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","article-title":"SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells","volume":"81","author":"Tong","year":"2021","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110525","article-title":"Metabolomics analysis of SNAT2-deficient cells: implications for the discovery of selective small-molecule inhibitors of an amino acid transporter","volume":"301","author":"Koe","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.2012.310","article-title":"Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer","volume":"107","author":"Kaira","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124406_bib18","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1111\/bph.13616","article-title":"Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer","volume":"173","author":"Coothankandaswamy","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib19","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino acid transporters in cancer and their relevance to \"glutamine addiction\": novel targets for the design of a new class of anticancer drugs","volume":"75","author":"Bhutia","year":"2015","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124406_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155486","article-title":"Crosstalk between tumor and stromal cells in pancreatic ductal adenocarcinoma","volume":"21","author":"Sperb","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6468","key":"10.1016\/j.biomaterials.2026.124406_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib22","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ccell.2025.06.021","article-title":"Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124406_bib23","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0119","article-title":"Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124406_bib24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-065X.2012.01155.x","article-title":"Metabolic reprogramming and metabolic dependency in T cells","volume":"249","author":"Wang","year":"2012","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124406_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124406_bib29","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","article-title":"GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41467-020-14374-1","article-title":"Targeting glutamine metabolism slows soft tissue sarcoma growth","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124406_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103813","article-title":"Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma","volume":"86","author":"Gao","year":"2025","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124406_bib32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/1097-0142(195711\/12)10:6<1138::AID-CNCR2820100608>3.0.CO;2-K","article-title":"Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease","volume":"10","author":"Magill","year":"1957","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00216936","article-title":"Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas","volume":"8","author":"Earhart","year":"1990","journal-title":"Invest. N. Drugs"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00170760","article-title":"Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON)","volume":"3","author":"Rahman","year":"1985","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124406_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309582","article-title":"Intelligent delivery systems in tumor metabolism regulation: exploring the path ahead","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib36","article-title":"Breaking the stromal barrier in pancreatic cancer: advances and challenges","volume":"1879","author":"Chakkera","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.biomaterials.2026.124406_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1287459","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Hartupee","year":"2024","journal-title":"Front. Immunol."},{"issue":"36","key":"10.1016\/j.biomaterials.2026.124406_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301257","article-title":"Targeted reprogramming of vitamin B(3) metabolism as a nanotherapeutic strategy towards chemoresistant cancers","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124406_bib39","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54963-y","article-title":"Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"issue":"762","key":"10.1016\/j.biomaterials.2026.124406_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9366","article-title":"Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer","volume":"16","author":"Chibaya","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124406_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121945","article-title":"Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis","volume":"292","author":"Qi","year":"2023","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124406_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1971","article-title":"Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies","volume":"5","author":"Katsumata","year":"2019","journal-title":"Sci. Adv."},{"issue":"46","key":"10.1016\/j.biomaterials.2026.124406_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci. Adv."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124406_bib45","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1021\/acs.jmedchem.6b01069","article-title":"Discovery of 6-Diazo-5-oxo-l-norleucine (DON) prodrugs with enhanced CSF delivery in monkeys: a potential treatment for glioblastoma","volume":"59","author":"Rais","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124406_bib46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-17-1148","article-title":"We're Nnt \"DON\" Yyt: Ootimal Ddsing and Ppodrug Ddlivery of 6-Diazo-5-oxo-L-norleucine","volume":"17","author":"Lemberg","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"issue":"7899","key":"10.1016\/j.biomaterials.2026.124406_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41746-025-01435-2","article-title":"Computational frameworks transform antagonism to synergy in optimizing combination therapies","volume":"8","author":"Chen","year":"2025","journal-title":"npj Digit. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","article-title":"Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression","volume":"19","author":"Fukuda","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124406_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm0297-177","article-title":"Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation","volume":"3","author":"Helmlinger","year":"1997","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0360-3016(00)00803-8","article-title":"Pancreatic tumors show high levels of hypoxia","volume":"48","author":"Koong","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biomaterials.2026.124406_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2020.04.018","article-title":"Hypoxia and pancreatic ductal adenocarcinoma","volume":"484","author":"Yamasaki","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41420-023-01334-z","article-title":"A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment","volume":"9","author":"Geyer","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biomaterials.2026.124406_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122574","article-title":"A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy","volume":"309","author":"Chen","year":"2024","journal-title":"Biomaterials"},{"issue":"8115","key":"10.1016\/j.biomaterials.2026.124406_bib55","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41586-026-10268-2","article-title":"Catabolism of extracellular glutathione supplies cysteine to support tumours","volume":"653","author":"Hecht","year":"2026","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124406_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc.2016.131","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124406_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124406_bib58","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124406_bib59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124406_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"33","key":"10.1016\/j.biomaterials.2026.124406_bib61","article-title":"Targeting glutamine metabolism transporter SLC25A22 enhances CD8+ T-Cell function and Anti-PD-1 therapy efficacy in cervical squamous cell carcinoma: integrated metabolomics, transcriptomics and T-Cell-Incorporated tumor organoid studies","volume":"12","author":"Ren","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124406_bib62","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.immuni.2016.03.016","article-title":"Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function","volume":"44","author":"Balmer","year":"2016","journal-title":"Immunity"},{"issue":"6434","key":"10.1016\/j.biomaterials.2026.124406_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0135","article-title":"T cell stemness and dysfunction in tumors are triggered by a common mechanism","volume":"363","author":"Vodnala","year":"2019","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124406_bib64","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","article-title":"Targeting hypoxic tumor microenvironment in pancreatic cancer","volume":"14","author":"Tao","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124406_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s43018-023-00649-1","article-title":"Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma","volume":"5","author":"Recouvreux","year":"2024","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124406_bib67","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jcmgh.2021.07.006","article-title":"Myeloid cell mediated immune suppression in pancreatic cancer","volume":"12","author":"Kemp","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"7972","key":"10.1016\/j.biomaterials.2026.124406_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124406_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124406_bib70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:07:44Z","timestamp":1785902864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":70,"alternative-id":["S0142961226004308"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124406","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124406"}}